1,2
Among these cardiometabolic alterations, MS has been
stressed, as it represents a set of risk factors, which consists
of alterations in the metabolism of carbohydrates
--- hyperinsulinemia, IR, glucose intolerance or DM2, lipid
metabolism alterations (increased triglycerides (TG) and/or
decreased cholesterol bound to high-density lipoprotein
[HDL]), abdominal obesity, and high blood pressure.3
The hepatic expression of MS is nonalcoholic fatty liver
disease (NAFLD), which is characterized by fat deposition
in the hepatocytes of patients with little or no alcohol
ingestion.4 In a study of 102 adults diagnosed with diabetes,
it was observed that almost half NAFLD, and they also
presented higher BMI and uric acid levels than individuals
without NAFLD.5